Cargando…

What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey

BACKGROUND: Multimorbidity and polypharmacy are very common in older adults in primary care. Ideally, general practitioners (GPs), should regularly review medication lists to identify inappropriate medication(s) and, where appropriate, deprescribe. However, it remains challenging to deprescribe give...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rozsnyai, Zsofia, Jungo, Katharina Tabea, Reeve, Emily, Poortvliet, Rosalinde K. E., Rodondi, Nicolas, Gussekloo, Jacobijn, Streit, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602330/ https://www.ncbi.nlm.nih.gov/pubmed/33129274 http://dx.doi.org/10.1186/s12877-020-01843-x

Ejemplares similares

How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
por: Mantelli, Sophie, et al.
Publicado: (2018)

Potentially inappropriate medication and attitudes of older adults towards deprescribing
por: Achterhof, Alexandra B., et al.
Publicado: (2020)

Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial
por: Jungo, Katharina Tabea, et al.
Publicado: (2023)

General practitioners’ deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries
por: Jungo, Katharina Tabea, et al.
Publicado: (2021)

Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial
por: Jungo, Katharina Tabea, et al.
Publicado: (2021)

Understanding older patients’ willingness to have medications deprescribed in primary care: a protocol for a cross-sectional survey study in nine European countries
por: Lüthold, Renata Vidonscky, et al.
Publicado: (2022)

Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland
por: Zechmann, Stefan, et al.
Publicado: (2019)

Life-course socioeconomic conditions, multimorbidity and polypharmacy in older adults: A retrospective cohort study
por: Jungo, Katharina Tabea, et al.
Publicado: (2022)

Managing hypertension in frail oldest-old—The role of guideline use by general practitioners from 29 countries
por: Roulet, Céline, et al.
Publicado: (2020)

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications
por: Jungo, Katharina Tabea, et al.
Publicado: (2021)

Systematic Review of Guidelines on Antihypertensive Treatment in Older Adults: SPRINTing to More Heterogeneity?
por: Bogaerts, Jonathan, et al.
Publicado: (2020)

Assessment of Appropriateness of Cardiovascular Preventive Medication in Adults ≥ 75 years
por: van der Ploeg, Milly, et al.
Publicado: (2020)

‘Optimising PharmacoTherapy In the multimorbid elderly in primary CAre’ (OPTICA) to improve medication appropriateness: study protocol of a cluster randomised controlled trial
por: Jungo, Katharina Tabea, et al.
Publicado: (2019)

Educating Homecare Nurses about Deprescribing of Medications to Manage Polypharmacy for Older Adults
por: Sun, Winnie, et al.
Publicado: (2021)

Polypharmacy and deprescribing: challenging the old and embracing the new
por: O’Donnell, Lisa Kouladjian, et al.
Publicado: (2022)

Deprescribing in Real Time: Hospitalized Septuagenarian With Polypharmacy
por: Famuyiro, Tolulope, et al.
Publicado: (2023)

A Study on the Perceptions of Korean Older Adult Patients and Caregivers about Polypharmacy and Deprescribing
por: Lee, Han-Gyul, et al.
Publicado: (2022)

Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity
por: Sallevelt, Bastiaan T. G. M., et al.
Publicado: (2021)

Do we AGREE on the targets of antihypertensive drug treatment in older adults: a systematic review of guidelines on primary prevention of cardiovascular diseases
por: Bogaerts, Jonathan M K, et al.
Publicado: (2021)

Correction to: Polypharmacy and deprescribing: Challenging the old and embracing the new
por: O’Donnell, Lisa Kouladjian, et al.
Publicado: (2022)

LESS-PHARMA Study: Identifying and Deprescribing Potentially Inappropriate Medication in the Elderly Population with Excessive Polypharmacy in Primary Care
por: Reus, Xisco, et al.
Publicado: (2022)

Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy
por: Bhadhuri, Arjun, et al.
Publicado: (2020)

“I Think Deprescribing as a Whole Is a Gap!”: A Qualitative Study of Student Pharmacist Perceptions about Deprescribing
por: Springer, Sydney P., et al.
Publicado: (2022)

Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients
por: Luymes, Clare H, et al.
Publicado: (2017)

Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines
por: van der Ploeg, Milly A., et al.
Publicado: (2019)

Effects of discontinuation of levothyroxine treatment in older adults: protocol for a self-controlled trial
por: Ravensberg, A Janneke, et al.
Publicado: (2023)

Polypharmacy and Medication-Related Problems in Hemodialysis Patients: A Call for Deprescribing
por: Alshamrani, Majed, et al.
Publicado: (2018)

Development and Validation of Nine Deprescribing Algorithms for Patients on Hemodialysis to Decrease Polypharmacy
por: Lefebvre, Melissa J., et al.
Publicado: (2020)

Assessment of the appropriateness of cardiovascular preventive medication in older people: using the RAND/UCLA Appropriateness Method
por: van der Ploeg, Milly A., et al.
Publicado: (2022)

Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study
por: Aubert, Carole E., et al.
Publicado: (2023)

Deprescribing and Polypharmacy for Medicare Beneficiaries Under Guardianship in Long-Term Care Facilities
por: Swenson, Tami
Publicado: (2020)

The effects of in-hospital deprescribing on potential prescribing omission in hospitalized elderly patients with polypharmacy
por: Kaminaga, Miho, et al.
Publicado: (2021)

Evaluating 10 years of state-funded GP training in GP offices in Switzerland
por: Baumann, Kim, et al.
Publicado: (2020)

Prescribing and deprescribing antihypertensive medication in older people by Dutch general practitioners: a qualitative study
por: van Middelaar, Tessa, et al.
Publicado: (2018)

Lower Performance in Orientation to Time and Place Associates with Greater Risk of Cardiovascular Events and Mortality in the Oldest Old: Leiden 85-Plus Study
por: Rostamian, Somayeh, et al.
Publicado: (2017)

Biomarkers versus traditional risk factors to predict cardiovascular events in very old adults: cross-validated prospective cohort study
por: Vaes, Bert, et al.
Publicado: (2020)

Healthcare Costs and Health-Related Quality of Life in Older Multimorbid Patients After Hospitalization
por: Salari, Paola, et al.
Publicado: (2023)

Knowledge and Attitudes of Student Pharmacists Regarding Polypharmacy and Deprescribing: A Cross-Sectional Study
por: Clark, Collin M., et al.
Publicado: (2020)

Emotional barriers and facilitators of deprescribing for older adults with cancer and polypharmacy: a qualitative study
por: Ramsdale, Erika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9enif4tdtt0l5sjkeb4jujbvkd